Novo Nordisk, Actavis End PrandiMet Patent Spat

Law360, New York (November 9, 2010, 2:34 PM EST) -- Novo Nordisk A/S and Actavis Pharma Manufacturing Pvt. Ltd. LLC have resolved a patent infringement suit over Actavis Pharma's bid for regulatory approval to make and sell a generic version of the diabetes drug PrandiMet.

Judge Paul G. Gardephe of the U.S. District Court for the Southern District of New York signed off on a stipulation and order of dismissal in the case Friday.

Novo Nordisk slapped Actavis Pharma and Actavis Inc. with a lawsuit in October 2009, after Actaviz Pharma filed an Abbreviated New Drug...
To view the full article, register now.